Michèle Geoffrion

2.7k citations

33 papers · 1.8k indexed · h-index 16

Clinical Biochemistry top 1%
- Advanced Glycation End Products research 5
Cancer Research top 5%
- MicroRNA in disease regulation 8
Immunology top 5%
- Atherosclerosis and Cardiovascular Diseases 7
- Phagocytosis and Immune Regulation 6
Molecular Biology top 10%
- Extracellular vesicles in disease 3
- Cell death mechanisms and regulation 3
Endocrinology, Diabetes and Metabolism top 10%
Epidemiology
- Autophagy in Disease and Therapy 4
Pathology and Forensic Medicine
- Alcohol Consumption and Health Effects 3

Co-authors: Ross W. Milne Katey J. Rayner Heidi M. McBride Timothy E. Shutt Denuja Karunakaran Lars Mäegdefessel Ulf Hedin My-Anh Nguyen
Cited by: Clinical Biochemistry Cancer Research Immunology
Journals: Nature Medicine (1 paper)ACS Nano (1 paper)Circulation Research (3 papers)
Partner nations: Canada United States Sweden

In The Last Decade

Michèle Geoffrion

33 papers receiving 1.8k citations

Peers

Countries citing papers authored by Michèle Geoffrion

Since Specialization

Citations

This map shows the geographic impact of Michèle Geoffrion's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michèle Geoffrion with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michèle Geoffrion more than expected).

Fields of papers citing papers by Michèle Geoffrion

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michèle Geoffrion. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michèle Geoffrion. The network helps show where Michèle Geoffrion may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Michèle Geoffrion, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michèle Geoffrion Line = papers co-authored together Michèle Geoffrion links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Age-Related Impairments in Immune Cell Efferocytosis and Autophagy Hinder Atherosclerosis Regression Arteriosclerosis Thrombosis and Vascular Biology ·Dominique Boucher,Sabrina Robichaud,Victoria Lorant,Jonathan Salazar‐León,Isam Suliman,Adil Rasheed,Leah I. Susser,Christina Emerton,Michèle Geoffrion,E.M.G.J. de Jong,Dawn M. E. Bowdish,Masanori Aikawa,Elena Aïkawa,Sasha A. Singh,Katey J. Rayner,Mireille Ouimet	2025	8
2	Hyperlipidemia-induced hematopoiesis is repressed by MLKL in endothelial cells of the splenic niche Nature Cardiovascular Research ·Adil Rasheed,Sabrina Robichaud,Taylor Dennison,My-Anh Nguyen,Michèle Geoffrion,Jordan N. Reed,Hailey Wyatt,Yacine Marouf,Adir Baxi,Richard Lee,Hilal Kazan,Mete Civelek,Coen van Solingen,Mireille Ouimet,Katey J. Rayner	2024	2
3	Mitochondrial Fragmentation Promotes Inflammation Resolution Responses in Macrophages via Histone Lactylation Molecular and Cellular Biology ·Leah I. Susser,My-Anh Nguyen,Michèle Geoffrion,Christina Emerton,Mireille Ouimet,Mireille Khacho,Katey J. Rayner	2023	39
4	ATF2 orchestrates macrophage differentiation and activation to promote antibacterial responses Journal of Leukocyte Biology ·Nusrah Rajabalee,Hannah Siushansian,Milani Weerapura,Stefania Berton,Fjolla Berbatovci,Breana G. Hooks,Michèle Geoffrion,Dabo Yang,Mary‐Ellen Harper,Katey J. Rayner,Alexandre Blais,Jim Sun	2023	7
5	miR-223 Exerts Translational Control of Proatherogenic Genes in Macrophages Circulation Research ·My-Anh Nguyen,Huy‐Dung Hoang,Adil Rasheed,Anne‐Claire Duchez,Hailey Wyatt,Mary Lynn Cottee,Tyson E. Graber,Leah C. Susser,Sabrina Robichaud,İbrahim Berber,Michèle Geoffrion,Mireille Ouimet,Hilal Kazan,Lars Mäegdefessel,Erin E. Mulvihill,Tommy Alain,Katey J. Rayner	2022	42
6	Loss of MLKL (Mixed Lineage Kinase Domain-Like Protein) Decreases Necrotic Core but Increases Macrophage Lipid Accumulation in Atherosclerosis Arteriosclerosis Thrombosis and Vascular Biology ·Adil Rasheed,Sabrina Robichaud,My-Anh Nguyen,Michèle Geoffrion,Hailey Wyatt,Mary Lynn Cottee,Taylor Dennison,Antonietta Pietrangelo,Richard Lee,Thomas A. Lagace,Mireille Ouimet,Katey J. Rayner	2020	52
7	Delivery of MicroRNAs by Chitosan Nanoparticles to Functionally Alter Macrophage Cholesterol Efflux in Vitro and in Vivo ACS Nano ·My-Anh Nguyen,Hailey Wyatt,Leah C. Susser,Michèle Geoffrion,Adil Rasheed,Anne‐Claire Duchez,Mary Lynn Cottee,Esther Afolayan,Eliya Farah,Zaina Kahiel,Marceline Côté,Suresh Gadde,Katey J. Rayner	2019	123
8	The Keap1–Nrf2 Stress Response Pathway Promotes Mitochondrial Hyperfusion Through Degradation of the Mitochondrial Fission Protein Drp1 Antioxidants and Redox Signaling ·Rasha Sabouny,Erik A. Fraunberger,Michèle Geoffrion,Andy Cheuk‐Him Ng,Stephen Baird,Robert A. Screaton,Ross W. Milne,Heidi M. McBride,Timothy E. Shutt	2017	95
9	Abstract 3: Targeting Macrophage Necroptosis for Therapeutic and Diagnostic Interventions to Treat Atherosclerosis Arteriosclerosis Thrombosis and Vascular Biology ·Denuja Karunakaran,Michèle Geoffrion,Lihui Wei,Wei Gan,Ljubica Perisic,Lars Mäegdefessel,Ulf Hedin,Subash Sad,Terrence D. Ruddy,Liang Guo,Frank D. Kolodgie,Renu Virmani,Katey J. Rayner	2016	1
10	Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis Science Advances ·Denuja Karunakaran,Michèle Geoffrion,Lihui Wei,Wei Gan,Laura M. Richards,Prakriti Shangari,Ella deKemp,Rachelle A Beanlands,Ljubica Perisic,Lars Mäegdefessel,Ulf Hedin,Subash Sad,Liang Guo,Frank D. Kolodgie,Renu Virmani,Terrence D. Ruddy,Katey J. Rayner	2016	227
11	Therapeutic Inhibition of miR-33 Promotes Fatty Acid Oxidation but Does Not Ameliorate Metabolic Dysfunction in Diet-Induced Obesity Arteriosclerosis Thrombosis and Vascular Biology ·Denuja Karunakaran,Laura M. Richards,Michèle Geoffrion,Danyk Barrette,Ryan Gotfrit,Mary‐Ellen Harper,Katey J. Rayner	2015	56
12	Abstract 692: Therapeutic Inhibition of miR-33 Does Not Promote Obesity, Insulin Resistance or Hepatic Lipid Accumulation Arteriosclerosis Thrombosis and Vascular Biology ·Denuja Karunakaran,Michèle Geoffrion,Danyk Barrett,Mary‐Ellen Harper,Christine Esau,Katey J. Rayner	2015	1
13	Role of Extracellular MicroRNAs in Atherosclerosis The FASEB Journal ·My-Anh Nguyen,Denuja Karunakaran,Michèle Geoffrion,Katey J. Rayner	2015	1
14	Macrophage Mitochondrial Energy Status Regulates Cholesterol Efflux and Is Enhanced by Anti-miR33 in Atherosclerosis Circulation Research ·Denuja Karunakaran,A. Brianne Thrush,My-Anh Nguyen,Laura M. Richards,Michèle Geoffrion,Ragunath Singaravelu,Eleni Ramphos,Prakriti Shangari,Mireille Ouimet,John Paul Pezacki,Kathryn J. Moore,Ljubica Perisic,Lars Mäegdefessel,Ulf Hedin,Mary‐Ellen Harper,Katey J. Rayner	2015	150
15	Netrin-1 promotes adipose tissue macrophage retention and insulin resistance in obesity Nature Medicine ·Bhama Ramkhelawon,Elizabeth J. Hennessy,Mickaël Ménager,Tathagat Dutta Ray,Frederick J. Sheedy,Susan Hutchison,Amarylis Wanschel,Scott R. Oldebeken,Michèle Geoffrion,Westley Spiro,George Miller,Ruth McPherson,Katey J. Rayner,Kathryn J. Moore	2014	202
16	Glyoxalase-1 overexpression in bone marrow cells reverses defective neovascularization in STZ-induced diabetic mice Cardiovascular Research ·Branka Vulesevic,Brian McNeill,Michèle Geoffrion,Drew Kuraitis,Joanne E. McBane,Marina Lochhead,Barbara C. Vanderhyden,Gregory S. Korbutt,Ross W. Milne,Erik J. Suuronen	2013	35
17	Knockdown of Glyoxalase 1 Mimics Diabetic Nephropathy in Nondiabetic Mice Diabetes ·Ferdinando Giacco,Xueliang Du,Vivette D. D’Agati,Ross W. Milne,Guangzhi Sui,Michèle Geoffrion,Michael Brownlee	2013	141
18	Glycation of LDL by Methylglyoxal Increases Arterial Atherogenicity Diabetes ·Naila Rabbani,Lisa Godfrey,Mingzhan Xue,Fozia Shaheen,Michèle Geoffrion,Ross W. Milne,Paul J. Thornalley	2011	133
19	The expression of apolipoprotein B epitopes is normal in LDL of diabetic and end-stage renal disease patients Diabetologia ·Sylvie Braschi,Michèle Geoffrion,Thu Anh Nguyen,Y. Gaudreau,R W Milne	2006	7
20	A mouse monoclonal antibody specific for mouse apoB48 and apoB100 produced by immunizing “apoB39-only” mice with mouse apoB48 Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids ·Anh Nguyen,Sylvie Braschi,Michèle Geoffrion,Loren G. Fong,Rosanne M. Crooke,Mark J. Graham,Stephen G. Young,Ross W. Milne	2006	12

About Michèle Geoffrion

Michèle Geoffrion is a scholar working on Clinical Biochemistry, Immunology and Cancer Research, having authored 33 papers that have together received 1.8k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (8 papers), Atherosclerosis and Cardiovascular Diseases (7 papers), Phagocytosis and Immune Regulation (6 papers), Advanced Glycation End Products research (5 papers), Autophagy in Disease and Therapy (4 papers), Extracellular vesicles in disease (3 papers), Alcohol Consumption and Health Effects (3 papers) and Cell death mechanisms and regulation (3 papers). The work is most often cited by research in Clinical Biochemistry (315 citations), Cancer Research (384 citations) and Immunology (493 citations). Michèle Geoffrion has collaborated with scholars based in Canada, United States and Sweden. Frequent co-authors include Ross W. Milne, Katey J. Rayner, Heidi M. McBride, Timothy E. Shutt, Denuja Karunakaran, Lars Mäegdefessel, Ulf Hedin, My-Anh Nguyen, Laura M. Richards and Kathryn J. Moore. Their work appears in journals such as Nature Medicine, ACS Nano and Circulation Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact